GENI (GENI) Stock Price & Analysis
GENI (GENI) rose 0.00% to USD 6.48 as of July 25, 2026 at 01:49 UTC, according to Nexqual real-time market data.
GENI last closed at USD 6.48; the session ranged USD 6.42–6.76 on volume of 3,129,454 shares. Market capitalization is —, with a 52-week range of USD 3.83–13.73 (NYQ). Source: Nexqual, July 25, 2026 at 01:49 UTC.
Key Statistics (as of July 25, 2026 at 01:49 UTC)
| Price | USD 6.48 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 6.48 |
| Open | USD 6.48 |
| Day Range | USD 6.42 – 6.76 |
| 52-Week Range | USD 3.83 – 13.73 |
| Volume | 3,129,454 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (GENI)
Nexqual's technical model rates GENI "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 01:49 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.59 (neutral) |
| vs SMA50 | Above (USD 6.03) |
| MACD | 0.12 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SRAD | Sportradar Group AG | USD 14.29 | ▲ 0.07% |
| RSI | Rush Street Interactive, Inc. | USD 31.43 | ▲ 0.7% |
| SRTA | Strata Critical Medical, Inc. | USD 5.04 | ▼ 0.79% |
| PSFE | Paysafe Limited | USD 7.95 | ▲ 0.76% |
| MQ | Marqeta, Inc. | USD 17.07 | ▼ 0.52% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:49 UTC. This page is informational and not investment advice.